Replies to post #129112 on Biotech Values

[jq1234]

It's a pretty good presentation. It showed why UFI has a place in the space:

Ultra-rapid absorption (TINS-50%-early) relative to analogs
and regular human insulin (RHI)
• Healthy Normal Response: 10 – 15 min
• Linjeta™: 8 – 18 min (NDA Formulation: 8 – 13 min)
• Humalog®: 25 min
• NovoLog®: 23 - 25 min
• RHI (Humulin® R): 40 – 55 min

I am not sure if the 3 candidates (BIOD-2AA BIOD-2FF BIOD-2HH) are variations from one analog or 3 different analogs.